HAL (France)
open access
AXL-directed antibody–drug conjugate therapy in soft-tissue sarcoma
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The journey of targeted drug conjugates in solid tumors: moving beyond antibody drug conjugates#273690
- The evolution of cellular therapies in sarcoma: Breakthroughs, challenges, and future directions#651926
- Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma#879815
- Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma#979967
- A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma#1112905
Record · ID 1390774
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive